In the molecule of the title compound, C 7 H 9 ClN 2 O 2 , the conformation is determined by intramolecular C-HÁ Á ÁO and C-HÁ Á ÁCl hydrogen bonds, which generate S(6) and S(5) ring motifs. The isopropyl group is almost perpendicular to the pyrimidine ring with torsion angles of À70.8 (3) and 56.0 (3) . In the crystal, two inversion-related molecules are linked via a pair of N-HÁ Á ÁO hydrogen bonds into R 2 2 (8) dimers; these dimers are connected into chains extending along the bc plane via an additional N-HÁ Á ÁO hydrogen bond and weaker C-HÁ Á ÁO hydrogen bonds. The crystal structure is further stabilized by a weak -interaction [3.6465 (10) Å ] between adjacent pyrimidine-dione rings arranged in a head-to-tail fashion, producing a three-dimensional network.
Related literature
For the biological activity of pyrimidine-2,4(1H,3H)-diones, see: Miyasaka et al. (1989) ; Tanaka et al. (1995) ; Hopkins et al. (1996) ; El-Brollosy et al. Koroniak et al. (1993) . For hydrogen-bond motifs, see: Bernstein et al. (1995) .
Experimental
2.1. Crystal data Table 1 Hydrogen-bond geometry (Å , ). Data collection: APEX2 (Bruker, 2009 ); cell refinement: SAINT (Bruker, 2009 ); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: SHELXTL (Sheldrick, 2008) ; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009 ).
S1. Comment
Pyrimidine-2,4-diones and their related derivatives have long been known for their diverse chemotherapeutic activities including antiviral activity against HIV (Miyasaka et al., 1989; Tanaka et al., 1995; Hopkins et al., 1996; El-Emam et al., 2004) . In addition, potent anticancer activity was observed for several pyrimidine-2,4-diones (Klein et al., 2001; Nencka et al., 2006) . In a continuation of our interest in the chemical and pharmacological properties of pyrimidine and uracil derivatives (Al-Omary et al., 2014; Haress et al., 2014 , El-Brollosy et al., 2009 , we have synthesized the title compound (I) as a precursor to the synthesis of a potential chemotherapeutic agent (Al-Turkistani et al., 2011) .
In the title compound ( Fig. 1) , the molecular conformation is stabilized by intramolecular C6-H6B···O2 and C5-H5···Cl1 hydrogen bonds incorporating S(6) and S(5) ring motifs respectively (Bernstein et al., 1995) . The isopropyl group is almost perpendicular to the N1/N2/C1-C4 ring with the C3-C4-C5-C7 and C3-C4-C5-C6 torsion angles of -70.8 (3)° and 56.0 (3)° respectively. In the crystal structure, two adjacent molecules are linked via a pair of N2-H1N2···O2 intermolecular hydrogen bonds forming inversion related R 2 2 (8) dimers ( Fig. 2) .; these dimers are connected into chains via N1-H1N1···O1 and weak C6-H6A···O1 hydrogen bonds extending along the bc plane. The crystal structure is further stabilized by a weak π···π interaction [3.6465 (10) Å] producing a three-dimensional network.
S2. Experimental
5-Isopropylbarbituric acid (8.51 g, 0.05 mol) was added portionwise with stirring to a mixture of phosphorus oxychloride (19.2 ml) and N,N-dimethyl aniline (10.3 ml) over a period of 10 minutes. The mixture was then heated under reflux for one hour. On cooling, the mixture was poured onto crushed ice (200 g m), stirred for 30 minutes and extracted with diethyl ether (400 ml). The ethereal extract was dried over anhydrous sodium sulfate and evaporated under vacuum at room temperature to yield the intermediate 5-isopropyl-2,4,6-trichloropyrimidine as a white waxy solid. 10% Sodium hydroxide (20 ml) was then added to the intermediate and the mixture was heated under reflux for 30 minutes. On cooling, the mixture was acidified with hydrochloric acid to pH 1-2 and the separated precipitate was filtered, washed with cold water and crystallized from ethanol to yield 6.98 g (74%) of the title compound (C 7 H 9 ClN 2 O 2 ) as colourless crystals. M.P.: 257-259 °C. 
S3. Refinement
The nitrogen-bound H-atoms were located in a difference Fourier map and were refined freely [N-H 0.83 (2) U eq (C) or 1.5 U eq (C) for methyl H atoms. A rotating group model was used for the methyl groups.
Figure 1
The molecular structure of the title compound with atom labels and 30% probability displacement ellipsoids. Geometric parameters (Å, º) 
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